Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m‐AMSA

Ronenn Roubenoff; Richard J. Jones; Judith E. Karp; Mary Betty Stevens

doi:10.1002/art.1780301017

Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m‐AMSA

Ronenn Roubenoff, Richard J. Jones, Judith E. Karp, Mary Betty Stevens

School of Medicine

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Abstract

We describe 2 patients in whom a sustained remission of longstanding rheumatoid arthritis occurred with treatment for acute myelogenous leukemia (cytosine arabinoside, daunorubicin, and m‐AMSA), even though both illnesses had been refractory to therapy with standard disease‐modifying agents. These 2 patients represent the first successful treatment of rheumatoid disease using such an approach.

Original language	English (US)
Pages (from-to)	1187-1190
Number of pages	4
Journal	Arthritis & Rheumatism
Volume	30
Issue number	10
DOIs	https://doi.org/10.1002/art.1780301017
State	Published - Oct 1987

ASJC Scopus subject areas

Immunology and Allergy
Rheumatology
Immunology
Pharmacology (medical)

Access to Document

10.1002/art.1780301017

Cite this

@article{8cbb51715d4349bcaf84ba23d46481e5,

title = "Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m‐AMSA",

abstract = "We describe 2 patients in whom a sustained remission of longstanding rheumatoid arthritis occurred with treatment for acute myelogenous leukemia (cytosine arabinoside, daunorubicin, and m‐AMSA), even though both illnesses had been refractory to therapy with standard disease‐modifying agents. These 2 patients represent the first successful treatment of rheumatoid disease using such an approach.",

author = "Ronenn Roubenoff and Jones, {Richard J.} and Karp, {Judith E.} and Stevens, {Mary Betty}",

year = "1987",

month = oct,

doi = "10.1002/art.1780301017",

language = "English (US)",

volume = "30",

pages = "1187--1190",

journal = "Arthritis & Rheumatism",

issn = "0004-3591",

publisher = "John Wiley and Sons Ltd",

number = "10",

}

TY - JOUR

T1 - Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m‐AMSA

AU - Roubenoff, Ronenn

AU - Jones, Richard J.

AU - Karp, Judith E.

AU - Stevens, Mary Betty

PY - 1987/10

Y1 - 1987/10

N2 - We describe 2 patients in whom a sustained remission of longstanding rheumatoid arthritis occurred with treatment for acute myelogenous leukemia (cytosine arabinoside, daunorubicin, and m‐AMSA), even though both illnesses had been refractory to therapy with standard disease‐modifying agents. These 2 patients represent the first successful treatment of rheumatoid disease using such an approach.

AB - We describe 2 patients in whom a sustained remission of longstanding rheumatoid arthritis occurred with treatment for acute myelogenous leukemia (cytosine arabinoside, daunorubicin, and m‐AMSA), even though both illnesses had been refractory to therapy with standard disease‐modifying agents. These 2 patients represent the first successful treatment of rheumatoid disease using such an approach.

UR - http://www.scopus.com/inward/record.url?scp=0023584316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023584316&partnerID=8YFLogxK

U2 - 10.1002/art.1780301017

DO - 10.1002/art.1780301017

M3 - Article

C2 - 3479115

AN - SCOPUS:0023584316

SN - 0004-3591

VL - 30

SP - 1187

EP - 1190

JO - Arthritis & Rheumatism

JF - Arthritis & Rheumatism

IS - 10

ER -

Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m‐AMSA

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this